Recombinant Campylobacter jejuni subsp. jejuni serotype O:6 Elongation factor Tu (tuf)

What is Elongation factor Tu (tuf) in Campylobacter jejuni and what is its function?

Elongation factor Tu (EF-Tu) is a highly conserved bacterial protein essential for protein biosynthesis. In Campylobacter jejuni, EF-Tu (encoded by the tuf gene) plays a crucial role in the elongation phase of translation by delivering aminoacyl-tRNAs to the ribosome. Beyond its canonical role in translation, EF-Tu has been found to have moonlighting functions in C. jejuni, including potential roles in adhesion, stress response, and virulence . The full-length protein consists of 399 amino acids with a sequence that includes GTP-binding domains and regions involved in interactions with aminoacyl-tRNAs and ribosomes .

How is the Elongation factor Tu (tuf) gene structured in C. jejuni genomes?

The tuf gene in C. jejuni is typically present as a single copy in the genome, unlike some other bacterial species that contain multiple copies. In C. jejuni subsp. jejuni serotype O:6 (strain 81116/NCTC 11828), the tuf gene encodes a protein with UniProt accession number A8FKQ5 . The gene is part of the core genome of C. jejuni and is highly conserved across different strains, making it a potential target for species identification and phylogenetic studies.

What expression systems are most effective for producing recombinant C. jejuni EF-Tu?

Escherichia coli is the most commonly used expression system for recombinant C. jejuni EF-Tu production . E. coli BL21 strain has been successfully employed to express the tuf gene, as demonstrated in the literature . The choice of expression vector is important, with systems that add affinity tags such as histidine (His) or glutathione S-transferase (GST) being particularly effective for subsequent purification steps . When expressing in E. coli, codon optimization may improve yields, although the genetic similarity between E. coli and C. jejuni often makes this unnecessary for the tuf gene.

What purification methods yield the highest purity and activity of recombinant EF-Tu?

For recombinant C. jejuni EF-Tu, affinity chromatography is the preferred initial purification method, with specific approaches depending on the attached tag. The literature demonstrates:

• For His-tagged EF-Tu: Nickel or cobalt-based immobilized metal affinity chromatography (IMAC) using His-trap columns .

• For GST-tagged EF-Tu: Glutathione-based affinity chromatography using GST-trap columns .

These methods can be implemented using automated systems such as the ÄKTA Explorer System for optimal reproducibility . Following affinity purification, additional steps may include:

• Size exclusion chromatography to remove aggregates and improve homogeneity

• Ion exchange chromatography for removing host cell protein contaminants

• Endotoxin removal for applications requiring endotoxin-free preparations

Purified recombinant EF-Tu typically appears as a distinct band at approximately 43-45 kDa when analyzed by SDS-PAGE, with purity levels exceeding 85% .

What are the critical factors affecting stability and activity of purified recombinant EF-Tu?

Several factors significantly impact the stability and functional activity of purified recombinant C. jejuni EF-Tu:

• Storage conditions: Optimal stability is achieved at -20°C or -80°C, with the latter preferred for extended storage periods. Multiple freeze-thaw cycles should be avoided as they can lead to protein denaturation and aggregation .

• Buffer composition: The presence of glycerol (typically 5-50%) in storage buffers enhances stability by preventing freeze-induced denaturation. The standard recommendation is 50% glycerol as the final concentration .

• Reconstitution parameters: For lyophilized protein, reconstitution should be performed in deionized sterile water to a concentration of 0.1-1.0 mg/mL .

• Shelf life considerations: Liquid formulations typically maintain stability for approximately 6 months at -20°C/-80°C, while lyophilized preparations can remain stable for up to 12 months under the same conditions .

• Functional integrity: GTP binding capacity and interaction with aminoacyl-tRNAs should be assessed regularly to confirm that the protein maintains its functional properties after storage.

How does the structure of C. jejuni EF-Tu compare to other bacterial EF-Tu proteins?

C. jejuni EF-Tu maintains the canonical three-domain structure observed in bacterial elongation factors, consisting of:

• Domain I (N-terminal): Contains the GTP/GDP binding site and possesses GTPase activity

• Domain II (middle): Involved in interactions with aminoacyl-tRNAs

• Domain III (C-terminal): Contributes to aminoacyl-tRNA binding and ribosomal interactions

What post-translational modifications have been identified in C. jejuni EF-Tu and how do they affect function?

• Phosphorylation: May regulate GTPase activity and interactions with binding partners

• Methylation: Could affect protein stability and ribosomal binding

• Glycosylation: Potentially impacting immunogenicity and host interactions

Oxygen-related stress has been demonstrated to alter the expression and possibly modification patterns of several C. jejuni membrane-associated proteins, which could include EF-Tu due to its partial membrane association in some conditions . Proteomic studies under varying environmental conditions suggest that PTMs may play a role in adapting EF-Tu function to different stress conditions encountered during host colonization.

Beyond protein synthesis, what moonlighting functions does C. jejuni EF-Tu exhibit?

In addition to its canonical role in translation, C. jejuni EF-Tu has been implicated in several moonlighting functions relevant to pathogenesis:

• Adhesion and virulence: In membrane proteomic studies, EF-Tu (TuF) has been identified as a protein that shows altered abundance under oxygen-acclimated conditions, suggesting a potential role in adapting to host environments . This moonlighting function may contribute to adhesion to host cells or abiotic surfaces.

• Immunomodulation: Recombinant GST-TuF has demonstrated reactions with both anti-C. jejuni immune sera and preimmune sera, indicating potential immunogenic properties that could influence host-pathogen interactions .

• Stress response: Similar to other bacterial species, C. jejuni EF-Tu may participate in responses to environmental stressors, particularly oxidative stress. Proteomic analyses have revealed significant changes in membrane protein composition, including proteins involved in adhesion and virulence, under oxygen-enriched conditions .

• Biofilm formation: The enhanced expression of certain membrane proteins in oxygen-acclimated C. jejuni correlates with increased adhesion to inert surfaces and biofilm formation capabilities, suggesting potential involvement of EF-Tu in these processes .

How can recombinant C. jejuni EF-Tu be used for studying bacterial pathogenesis mechanisms?

Recombinant C. jejuni EF-Tu serves as a valuable tool for investigating multiple aspects of C. jejuni pathogenesis:

• Adhesion studies: Using purified EF-Tu in binding assays with epithelial cell lines to assess its role as an adhesin, similar to studies with other bacterial pathogens. This is particularly relevant given the observed upregulation of various adhesion-related proteins under oxygen-acclimated conditions .

• Host-pathogen interaction models: Employing labeled recombinant EF-Tu to trace its interactions with host cell receptors and components of the extracellular matrix.

• Virulence regulation: Comparing EF-Tu expression and modification patterns between virulent and avirulent strains to identify correlations with pathogenicity.

• Stress response mechanisms: Utilizing recombinant EF-Tu to examine structural and functional changes under various stress conditions relevant to host colonization, such as oxidative stress, nutrient limitation, and pH variations .

What is the potential of C. jejuni EF-Tu as a diagnostic marker or vaccine candidate?

Recombinant C. jejuni EF-Tu shows promising characteristics for both diagnostic and vaccine applications:

• Diagnostic potential:

  • Antigenicity studies have demonstrated that recombinant GST-TuF reacts with anti-C. jejuni immune sera, indicating its potential utility in serological assays .

  • The conservation of EF-Tu across C. jejuni strains makes it a potentially reliable marker for species-specific detection.

  • The protein's stability and ease of recombinant production enhance its practicality for diagnostic kit development.

• Vaccine candidate properties:

  • As a conserved protein across C. jejuni strains, EF-Tu could potentially elicit protection against multiple serotypes.

  • Its demonstrated antigenicity suggests an ability to stimulate immune responses .

  • The potential moonlighting functions in adhesion and virulence make it a rational target for vaccine development aimed at preventing bacterial colonization.

How does C. jejuni EF-Tu compare with other C. jejuni recombinant proteins in terms of research applications?

In comparison to other recombinant C. jejuni proteins, EF-Tu possesses both advantages and limitations:

Table 1: Comparative Analysis of Selected Recombinant C. jejuni Proteins

Data derived from antigenicity studies of multiple recombinant C. jejuni proteins .

Unlike some highly specific antigens like rGST-AhpC, rHis-Omp18, and rHis-PEB1 that demonstrated universal and specific antigenicities, rGST-TuF showed reactions with both anti-serum and preimmune serum . This suggests that while EF-Tu is highly conserved and readily detectable, its specificity may be lower than some other C. jejuni proteins for certain applications.

What are the most common challenges in expressing and purifying recombinant C. jejuni EF-Tu?

Researchers commonly encounter several challenges when working with recombinant C. jejuni EF-Tu:

• Protein solubility issues: EF-Tu may form inclusion bodies when overexpressed in E. coli, requiring optimization of expression conditions (temperature, inducer concentration, duration).

• Contamination with endotoxins: As EF-Tu is typically expressed in gram-negative E. coli, endotoxin contamination can interfere with immunological studies.

• Protein activity preservation: Maintaining the functional activity of EF-Tu throughout purification requires careful buffer selection and handling procedures.

• Tag interference: Affinity tags may affect protein folding or function, necessitating validation of tagged protein activity or tag removal strategies.

• Batch-to-batch consistency: Achieving reproducible yields and activity levels between different preparation batches requires standardized protocols.

How can researchers optimize experimental design for studying C. jejuni EF-Tu under various environmental conditions?

To effectively study C. jejuni EF-Tu under different environmental conditions, consider the following optimization strategies:

• Oxygen exposure studies: Implement controlled gas mixtures to simulate the microaerobic to aerobic transition experienced during transmission. For example, compare protein expression and modifications between standard microaerobic conditions (5% O₂, 10% CO₂, 85% N₂) and oxygen-acclimated conditions (19% O₂, 10% CO₂, 71% N₂) .

• Growth media selection: Compare protein expression in rich media (e.g., BHI broth) versus minimal media to assess nutrient-dependent regulation.

• Temperature variation: Examine expression patterns at different temperatures relevant to environmental (ambient) versus host (37°C/42°C) conditions.

• Stress exposure protocols: Design experiments with controlled exposure to specific stressors (oxidative agents, bile salts, pH shifts) with appropriate controls.

• Time-course studies: Implement sampling at multiple time points to capture dynamic changes in protein expression and modification.

Table 2: Experimental Conditions for Studying C. jejuni EF-Tu Expression

Adapted from experimental protocols for C. jejuni membrane protein analysis .

What analytical methods provide the most comprehensive characterization of recombinant C. jejuni EF-Tu?

A multi-technique approach yields the most comprehensive characterization of recombinant C. jejuni EF-Tu:

• Structural analysis:

  • Circular Dichroism (CD) spectroscopy for secondary structure assessment

  • Nuclear Magnetic Resonance (NMR) or X-ray crystallography for high-resolution structural information

  • Differential Scanning Calorimetry (DSC) for thermal stability evaluation

• Functional assessment:

  • GTPase activity assays to confirm enzymatic function

  • Aminoacyl-tRNA binding assays to verify biological activity

  • Surface Plasmon Resonance (SPR) for measuring interaction kinetics with binding partners

• Post-translational modification mapping:

  • Mass spectrometry techniques including:

    • MALDI-TOF MS for protein identification

    • LC-MS/MS for detailed PTM mapping

    • Phosphoproteomic analysis for specific phosphorylation site identification

• Immunological characterization:

  • Western blotting with both anti-C. jejuni immune sera and preimmune sera

  • Enzyme-linked immunosorbent assays (ELISA) for quantitative antigenicity assessment

  • Epitope mapping to identify immunodominant regions

• Interaction studies:

  • Pull-down assays to identify protein-protein interactions

  • Cell adhesion assays to evaluate binding to host cell components

  • Cryo-electron microscopy for ribosome-bound structural studies